(NASDAQ:ARGX – Free Report) had its price target lifted by Piper Sandler from $620.00 to $725.00 in a research report report published on Tuesday morning,Benzinga reports. The brokerage currently has ...
Diagnosis Superior vena cava syndrome due to thrombotic obstruction ... node modification for treatment of inappropriate sinus tachycardia which, over a period of 5 years, had been refractory ...